documents: FDA-2026-N-10429-0001
Data license: Public Domain (U.S. Government data) · Data source: Regulations.gov API (General Services Administration)
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | comment_end_datetime | perpetual_docket | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2026-N-10429-0001 | FDA | FDA-2026-N-10429 | Design and Safety Considerations for Clinical Trials Involving Ibogaine Drug Products; Request for Information | Notice | Requests for Information (RFI) | 2026-10-06 | 2026 | 10 | 2026-10-06 | 2026-11-20 | 2026-11-21 04:59:59 | 0 | 2026-11-18 10:00:52 | 2026-20427 | 1 | 0 | 09000064b962e7b9 |